Learn about Clinical Fellowships aimed at providing junior-level physicians experience in biomedical research - in both lab and clinical settings.

For NIAMS staff, students, and fellows: Find housing, campus, and trainee information, as well as a list of services provided by NIH.

Statement for the Record Senate Subcommittee on Labor-HHS-Education Appropriations June 15, 2015 Stephen I. Katz, M.D., Ph.D., Director National Institute of Arthritis and Musculoskeletal and Skin Diseases _______________________________________ Mr. Chairman and Members of the Committee: I am pleased to present the President’s fiscal year (FY) 2016 budget request for the

March 2014 Organization Chart View a larger version of the organization chart. Top Appropriation Language NATIONAL INSTITUTES OF HEALTH National Institute of Arthritis and Musculoskeletal and Skin Diseases For carrying out section 301 and title IV of the PHS Act with respect to arthritis and musculoskeletal and skin diseases, [$520,053,000]

Statement to the Senate Appropriations Subcommittee May 11, 2011 (historical) Stephen I. Katz, M.D., Ph.D., Director National Institute of Arthritis and Musculoskeletal and Skin Diseases _______________________________________ Mr. Chairman and Members of the Committee: I am pleased to present the President’s Fiscal Year 2012 Budget for the National Institute of Arthritis

Applying for a grant can be challenging - understanding the process can help. The resources on this page provide information on NIAMS’s grant application guidelines and policies, and resources to learn more about the NIH grant process.

NIH prior approval is required for any reduction of effort of 25% or more from the level that was approved at the time of the initial competing year award, or a change of 25% or more from a previously approved reduction in effort level as reflected in a revised Notice

At NIH, generally all recipients may extend the final budget period of the previously approved project period one time for a period of up to 12 months beyond the original expiration date shown in the Notice of Award, if, as referenced in the NIH Grants Policy Statement: No additional funds

Change of Recipient Organization (Transfers) for NIAMS

NIAMS funded research has led to breakthroughs and new treatments, helping people live longer, healthier lives, and building the research foundation that drives discovery. Learn more about some of the funded research programs currently underway.

The NIH defines a clinical trial as a research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include placebo or other control) to evaluate the effects of those interventions on health-related biomedical or behavioral outcomes. Clinical trials range from small

The Exploratory Clinical Trial Grant Program fosters the development and implementation of interventional exploratory clinical trials aimed at providing clinically meaningful improvements in symptoms, function or disease course for patients with rheumatic, musculoskeletal or skin diseases. The trials must address research questions related to the mission and goals of the

This public-private partnership seeks to develop new ways of identifying and validating promising biological targets for diagnostics and drug development.

This Notice of Funding Opportunity (NOFO) encourages Research Project Grant (R01) applicants to pursue clinical observational (CO) studies to obtain data necessary for designing future clinical studies for musculoskeletal, rheumatic, or skin diseases or conditions. Research data from observational studies can enhance clinical study design by providing essential information about

The following are commonly asked questions and their answers about what happens after submitting a grant application and who to contact before and after the scientific review of the application.

Per notice NOT-OD-26-019, NIH will no longer require applicants requesting $500,000 or more in direct costs (excluding consortium F&A costs) in any one budget period to contact the funding Institute or Center (IC) before application submission.

ClinicalTrials.gov is a consumer-friendly database with information on clinical studies funded and/or sponsored by the NIH, other federal agencies, and private industry. The database was developed by NIH, through its National Library of Medicine (NLM), in collaboration with the Food and Drug Administration (FDA). The Food and Drug Administration Amendments

The Osteoarthritis Initiative (OAI) seeks to improve diagnosis and monitoring of osteoarthritis (OA) and foster development of new treatments.

NIAMS has standardized procedures and provides templates to ensure compliance and the safety of human subjects.

Peer review of properly completed applications submitted in response to the Program Announcements will be conducted by the NIAMS AMS Clinical Trials Review Committee. This review committee will provide expertise in NIAMS disease areas and in clinical trial methodology.